Show simple item record

dc.contributor.authorMcLaughlin, Gavin
dc.contributor.authorBaumann, Michael H.
dc.contributor.authorKavanagh, Pierce V.
dc.contributor.authorMorris, Noreen
dc.contributor.authorPower, John D.
dc.contributor.authorDowling, Geraldine
dc.contributor.authorTwamley, Brendan
dc.contributor.authorO'Brien, John
dc.contributor.authorHessman, Gary
dc.contributor.authorWestphal, Wolker
dc.contributor.authorWalther, Donna
dc.contributor.authorBrandt, Simon D.
dc.date.accessioned2019-04-23T08:22:47Z
dc.date.available2019-04-23T08:22:47Z
dc.date.copyright2018-04
dc.date.issued2018-09
dc.identifier.citationGavin McLaughlin et al (2018). Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomers. Drug Testing and Analysis. Sep;10(9):1404-1416. doi: 10.1002/dta.2396.en_US
dc.identifier.issn1942-7603
dc.identifier.urihttps://research.thea.ie/handle/20.500.12065/2640
dc.description.abstractThe availability of new psychoactive substances on the recreational drug market continues to create challenges for scientists in the forensic, clinical and toxicology fields. Phenmetrazine (3-methyl-2-phenylmorpholine) and an array of its analogs form a class of psychostimulants that are well documented in the patent and scientific literature. The present study reports on two phenmetrazine analogs that have been encountered on the NPS drug market following the introduction of 3-fluorophenmetrazine (3-FPM), namely 4-methylphenmetrazine (4-MPM) and 3-methylphenmetrazine (3-MPM). This study describes the syntheses, analytical characterization and pharmacological evaluation of the positional isomers of MPM. Analytical characterizations employed various chromatographic, spectroscopic and mass spectrometric platforms. Pharmacological studies were conducted in order to assess whether MPM isomers might display stimulant-like effects similar to the parent compound phenmetrazine. The isomers were tested for their ability to inhibit uptake or stimulate release of tritiated substrates at dopamine, norepinephrine and serotonin transporters using in vitro transporter assays in rat brain synaptosomes. The analytical characterization of three vendor samples revealed the presence of 4-MPM in two of the samples and 3-MPM in the third sample, which agreed with the product label. The pharmacological findings suggest that 2-MPM and 3-MPM will exhibit stimulant properties similar to the parent compound phenmetrazine, whereas 4-MPM may display entactogen properties more similar to MDMA. The combination of test purchases, analytical characterization, targeted organic synthesis and pharmacological evaluation of NPS and their isomers is an effective approach for the provision of data on these substances as they emerge in the marketplace.en_US
dc.formatPDFen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofDrug Testing and Analysisen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/ie/*
dc.subjectPsychotropic drugsen_US
dc.subjectDesigner drugsen_US
dc.subjectPsychostimulantsen_US
dc.titleSynthesis, analytical characterization and monoamine transporter activity of the new psychoactive substance 4- methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomersen_US
dc.typeArticleen_US
dc.description.peerreviewyesen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-2496-8396
dc.rights.accessOpen Accessen_US
dc.subject.departmentFaculty of Science and Healthen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland